脑苷肌肽辅助治疗脑梗死老年患者的临床分析  

Clinical Analysis of Adjuvant Therapy in Elderly Patients With Cerebral Infarction and Ignotin

作　　者：汤为民[1] 柴大均 

机构地区：[1]吉化集团公司总医院特诊科,吉林132022

出　　处：《中国继续医学教育》2016年第5期142-143,共2页China Continuing Medical Education

摘　　要：目的探讨脑苷肌肽辅助治疗脑梗死老年患者的效果。方法抽选老年脑梗死患者83例随机数字表法分为观察组(42例)和对照组(41例)。对照组患者给予常规治疗,观察组在此基础上添加脑苷肌肽辅助治疗,对比两组患者治疗效果差异。结果观察组治疗有效率为92.9%,对照组治疗有效率为78.0%,对比差异有统计学意义(P<0.05)。两组患者治疗过程中均无明显不良反应,肝肾功能无异常。结论脑苷肌肽辅助治疗老年脑梗死患者效果良好,无不良反应。Objective To investigate the treatment of elderly patients with cerebral infarction cattle encephalon glycoside and ignotin injetion effect. Methods 83 cases of senile cerebral infarction patients selected were randomly divided into observation group（42 cases） and control group（41 cases）. The control group were given routine treatment, observe add cattle encephalon glycoside and ignotin injection adjuvant treatment group on the basis of this, compared two groups of patients with treatment effect differences. Results The effective rate of observation group was 92.9%, and the effective rate of control group was 78.0%, the difference was significant（P〈0.05）. The two groups of patients in the treatment process were no significant adverse reactions, liver and kidney function without exception. Conclusion The effect of adjuvant therapy in elderly patients with cerebral infarction Naoganjitai good, no adverse reaction.

关 键 词：脑苷肌肽 脑梗死 老年 

分 类 号：R743[医药卫生—神经病学与精神病学]